What is the MDQ Measure for Assessing Bipolar Disorder?
Bipolar disorder affects almost 1 in 20 people during their...
Read article
Gain a better understanding of the nuances of bipolar spectrum disorders with cognitive assessments and symptom tracking in Creyos Health.
Facilitate early detection, ongoing monitoring, and pair with cognitive performance testing for patients with symptoms of bipolar disorder, in the clinic or at home.
Simplify assessments with a standardized tool, delivered digitally through the Creyos Health platform, with automated MDQ scoring and reports.
Benchmark and continuously evaluate symptom progression with a centralized patient health record that includes longitudinal data, automatically updated within the Creyos patient record.
Over 80% of cases are considered serious—more than any other mood disorder. Find out how Creyos can support patients with comprehensive screening and treatment.
Review our guide below for a complete list of standardized questionnaires available in Creyos.
Despite its seriousness, bipolar disorder is often misdiagnosed as depression, especially on first presentation. The MDQ questionnaire offered in Creyos is a 13-question self-assessment that effectively screens for bipolar disorder, offering:
Patients can complete the MDQ questionnaire in person through the Creyos Health platform on an in-clinic device or at home through a provided link.
In a series of 13 yes/no questions, the MDQ questionnaire assesses a patient’s history of manic or hypomanic symptoms and behaviors.
Creyos Health automatically provides MDQ scoring and reports. A cutoff score of 7 provides good sensitivity and specificity for independent diagnosis of bipolar spectrum disorder.
Healthcare providers can discuss results with patients and plan for follow-up assessments to track change over time.
Misdiagnosis, inadequate support, years of waiting for treatment—these are the lesser-discussed side effects of bipolar disorder. But with comprehensive, early screening using tools like the MDQ questionnaire and the PHQ-9, patients can overcome and avoid potentially dangerous consequences of the condition.
Administering these assessments through Creyos can reduce administrative burden and help patients get the timely treatment they need. Get a comprehensive view of all our standardized questionnaires in this guide.
The MDQ is a self-administered bipolar questionnaire that takes about 5 minutes to complete. It contains 13 yes/no items that assess a history of manic or hypomanic symptoms and behaviors, including two questions on symptom co-occurrence (more than one symptom at the same time) and impaired functioning (symptoms causing real-world problems). A total score is calculated based on the 13 main items.
In Creyos Health, if a patient scores 7 or higher, answers “yes” to co-occurrence of multiple symptoms during the same time period, and “moderate” or “severe” to the problems caused by symptoms, then a positive screen is indicated.
With Creyos, the MDQ can be easily administered by a technician or mental health professional, on a tablet in a clinic or via email for the patient to complete at home. This flexibility means that healthcare providers can maximize their appointment time with a patient to discuss results.
Creyos uses APIs to integrate with a variety of electronic health systems and has a built-in integration with athenahealth. Our platform automatically collects, scores, and organizes results from each questionnaire and adds them to the patient’s EHR.
Bipolar disorder affects almost 1 in 20 people during their...
Read article
Read article
About half of those who experience a mental illness during...
Read article